Market Report · July 15, 2026
Report Feature
Enteral Feeding Formula Market Trends and Forecast
The future of the global enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications. The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028 with a CAGR of 7.0% from 2023 to 2028 The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Enteral Feeding Formula by Segment
The study includes trends and forecast for the global enteral feeding formula market by product, stage, application, end use industry, and region, as follows:
Enteral Feeding Formula by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
- Standard Formulas
- Disease Specific
- Diabetic Formulas
- Renal Formulas
- Hepatic Formulas
- Pulmonary Formulas
- Other Disease Specific Formulas
- Peptide Based Formulas
- Other
Enteral Feeding Formula by Stage [Value ($B) Shipment Analysis from 2017 to 2028]:
- Adults
- Pediatric
Enteral Feeding Formula by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
- Oncology
- Gastrointestinal Diseases
- Neurological Disorders
- Diabetes
- Other
Enteral Feeding Formula by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:
- Hospitals
- Long Term Care facilities
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies & Hospices
Enteral Feeding Formula by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Enteral Feeding Formula Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, enteral feeding formula companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the enteral feeding formula companies profiled in this report include-
Enteral Feeding Formula Market Insights
- Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.
- Within this market, gastrointestinal diseases are expected to witness the highest growth over the forecast period due to increasing cases of gastrointestinal diseases and disorders among population.
- North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.
Features of the Enteral Feeding Formula
- Market Size Estimates: Enteral feeding formula market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Enteral feeding formula market size by various segments, such as product, stage, application, end use industry, and region
- Regional Analysis: Enteral feeding formula market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different products, stages, applications, end use industries, and regions for the enteral feeding formula market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the enteral feeding formula market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the enteral feeding formula market size?
Answer: The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028.
Q2. What is the growth forecast for enteral feeding formula market?
Answer: The global enteral feeding formula market is expected to grow with a CAGR of 7.0% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the enteral feeding formula market?
Answer: The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.
Q4. What are the major segments for enteral feeding formula market?
Answer: The future of the enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications.
Q5. Who are the key enteral feeding formula companies?
Answer: Some of the key enteral feeding formula companies are as follows:
Answer: The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028.
Q2. What is the growth forecast for enteral feeding formula market?
Answer: The global enteral feeding formula market is expected to grow with a CAGR of 7.0% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the enteral feeding formula market?
Answer: The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.
Q4. What are the major segments for enteral feeding formula market?
Answer: The future of the enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications.
Q5. Who are the key enteral feeding formula companies?
Answer: Some of the key enteral feeding formula companies are as follows:
- Abbott
- Nestlé S.A
- Danone S.A
- Fresenius Kabi
- B. Braun Melsungen AG
Q6. Which enteral feeding formula segment will be the largest in future?
Answer: Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.
Q7. In enteral feeding formula market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
Answer: Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.
Q7. In enteral feeding formula market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
